Infectious Diseases (all articles)
Largest global vaccine confidence survey reveals hesitancy hotspots
14 Sep, 2020 | 01:16h | UTCThe Lancet Infographics: How global perceptions of vaccines have changed
Commentary on Twitter
New research mapping global trends in vaccine confidence across 149 countries between 2015-19 & based on data from over 284,000 adults surveyed about their views on whether vaccines are important, safe and effective, reveals vaccine hesitancy hotspots https://t.co/cbgCLEFF0C
— The Lancet (@TheLancet) September 10, 2020
Updated meta-analysis: Drug treatments for Covid-19
14 Sep, 2020 | 01:04h | UTCDrug treatments for covid-19: living systematic review and network meta-analysis – The BMJ
Commentary on Twitter
https://twitter.com/RSiemieniuk/status/1304447644438327297
Carefully implemented infection-control measures can prevent COVID-19 transmission in hospitals
14 Sep, 2020 | 01:12h | UTCOriginal study: Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center – JAMA Network Open
Fauci says U.S. won’t get back to normal until late 2021
14 Sep, 2020 | 00:59h | UTCFauci says U.S. won’t get back to normal until late 2021 – NBC News
See also: Fauci says normal life may not be back until the end of 2021 – CNN
AstraZeneca resumes Covid-19 vaccine trials in the U.K.
14 Sep, 2020 | 01:01h | UTCAstraZeneca resumes Covid-19 vaccine trials in the U.K. – STAT
See also: The ethics of pausing a vaccine trial in the midst of a pandemic: a conversation with Ruth Faden – STAT AND University of Oxford resumes vaccine trial
A COVID-19 vaccine may be only 50% effective. Is that good enough?
14 Sep, 2020 | 01:03h | UTCA COVID-19 Vaccine May Be Only 50% Effective. Is That Good Enough? – NPR
[Abstract Only] Randomized trial: Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy
14 Sep, 2020 | 00:58h | UTC
The emergence of SARS-CoV-2 in Europe and North America
11 Sep, 2020 | 01:48h | UTCThe emergence of SARS-CoV-2 in Europe and North America – Science
Commentary: How coronavirus took hold in North America and in Europe – University of Arizona
Commentary on Twitter
"Our analyses … show that intensive testing and contact tracing could have prevented #SARSCoV2 from becoming established" in the United States and Europe
Just published @ScienceMagazine https://t.co/ywVKe3YteI @LemeyLab and collaborators pic.twitter.com/7AaB7Z7TeJ— Eric Topol (@EricTopol) September 10, 2020
Cochrane evidence on COVID-19: a round-up
11 Sep, 2020 | 01:47h | UTCCochrane evidence on COVID-19: a round-up – Evidently Cochrane
[Preprint] Transmission dynamics of COVID-19 in household and community settings in the United Kingdom
11 Sep, 2020 | 01:45h | UTC
Commentary on Twitter
Estimate of 37% (95% CI: 31-43%) secondary attack rate within UK households during early stages of pandemic (i.e. probability of transmission between first case and each household contact) https://t.co/rUTP70cbuA via @sbfnk pic.twitter.com/H8HjNku62F
— Adam Kucharski (@adamjkucharski) September 10, 2020
NSAIDs like ibuprofen not tied to severe COVID-19, death
11 Sep, 2020 | 01:42h | UTCNSAIDs like ibuprofen not tied to severe COVID-19, death – CIDRAP
The lessons we’ve learned from the Covid-19 response, according to Anthony Fauci
11 Sep, 2020 | 01:40h | UTCThe lessons we’ve learned from the Covid-19 response, according to Anthony Fauci – STAT
Commentary on Twitter
Fauci's lessons learned on Covid-19, in short:
* Never underestimate the potential impact of an outbreak.
* Scientifically sound research matters.
* Adapt to new information
* It's past time to address health care disparities.https://t.co/Ju7vm6iOQg— Jason Ukman (@JasonUkman) September 10, 2020
Editorial: Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine
11 Sep, 2020 | 01:33h | UTC
Preliminary randomized trial evaluated recombinant human granulocyte colony–stimulating factor for patients with COVID-19 and lymphopenia
11 Sep, 2020 | 01:36h | UTCInvited Commentary: Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)—Beware of Blind Spots
Commentary on Twitter
Preliminary findings from a randomized clinical trial suggest that rhG-CSF treatment should be studied in larger trials and in a broader range of patients with #COVID19 https://t.co/SjsoWOkEXg
— JAMA Internal Medicine (@JAMAInternalMed) September 10, 2020
Bacterial and fungal superinfections in critically ill patients with COVID-19
11 Sep, 2020 | 01:28h | UTC
Commentary on Twitter
Bacterial/fungal superinfections in critically ill #COVID19 pts: true prevalence still elusive. Underestimation of late superinfection risk may occur in #ICU; confounding factors also hamper identification of most frequently associated bacteria #COVIDFOAM https://t.co/iDAyOwYekr pic.twitter.com/Z7N4V7tc7q
— Intensive Care Medicine (@yourICM) September 10, 2020
Perspective: Fairly prioritizing groups for access to COVID-19 vaccines
11 Sep, 2020 | 01:34h | UTCFairly Prioritizing Groups for Access to COVID-19 Vaccines – JAMA
Audio interview: Guidelines for Covid-19 vaccine deployment
11 Sep, 2020 | 01:29h | UTCAudio Interview: Guidelines for Covid-19 Vaccine Deployment – New England Journal of Medicine
The underdog coronavirus vaccines that the world will need if front runners stumble
11 Sep, 2020 | 01:20h | UTCThe underdog coronavirus vaccines that the world will need if front runners stumble – Nature
New easy-to-use score for predicting risk of death in patients hospitalized with Covid-19
10 Sep, 2020 | 09:51h | UTCCommentaries: Discovery of four COVID-19 risk groups helps guide treatment – University of Edinburgh AND Expert reaction to a study looking at predicting the risk of death in hospitalised COVID-19 patients – Science Media Centre
Commentary on Twitter
NEW #BMJResearch finds that an easy-to-use score for predicting risk of death in adult patients admitted to hospital with #COVID19 outperforms existing scores and can be used to support treatment decisions @ProfCalumSemple @ISARIC1
https://t.co/2J9S3mqG5h— The BMJ (@bmj_latest) September 10, 2020
[Abstract Only] Randomized trial: Antibiotics vs. no therapy in kidney transplant recipients with asymptomatic bacteriuria
11 Sep, 2020 | 01:10h | UTC
Commentary on Twitter
More data ❌ screening/Rxing asymptomatic bacteriuria in kidney transplantation
199 KTx recipients (>2 mo out) randomized to Rx/no Rx for ASB
Rx arm had
💊No ⬇️ in symptomatic UTI
💊5x more ABx exposure
💊subsequent bacteriuria w resistant bacteria #TxIDhttps://t.co/a7aVjIJj0z pic.twitter.com/ngTkJLHCfU— Ilan Schwartz is on🦋 (@GermHunterMD) September 10, 2020
Why COVID-19 is more deadly in people with obesity—even if they’re young
10 Sep, 2020 | 09:47h | UTCWhy COVID-19 is more deadly in people with obesity—even if they’re young – Science
Clinical outcomes in young adults hospitalized with COVID-19
10 Sep, 2020 | 09:49h | UTCClinical Outcomes in Young US Adults Hospitalized With COVID-19 – JAMA Internal Medicine
Editorial: Regardless of Age, Obesity and Hypertension Increase Risks With COVID-19
Commentary: Obesity greatest risk factor for young adults with COVID-19 – MedicalXpress
Commentary on Twitter
18 to 34 years old #COVID19 hospitalized outcomes:
✔️21% intensive care,
✔️10% mechanical ventilation
✔️2.7% died.
✔️Morbid obesity, hypertension & diabetes associated with⬆️risks of adverse events.
✔️+ ½ requiring hospitalization: Black or Hispanic⚓️https://t.co/kcs2cery7s pic.twitter.com/ASVB943Bhc
— Medtorek (@Medtorek) September 9, 2020
Study: Kids with COVID-19, flu equally prone to severe illness
10 Sep, 2020 | 09:45h | UTCKids with COVID-19, flu equally prone to severe illness – CIDRAP
Original study: Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children – JAMA Network Open
Commentary on Twitter
A study comparing 315 children with #COVID19 and 1402 children with seasonal #influenza showed no statistically significant differences in hospitalization rates, hospitalization in intensive care and use of mechanical ventilators between the 2 groups.https://t.co/jLW9IHEuxi
— Cristina Dragani (@CristinaDragani) September 9, 2020
Opinion: Halting the Oxford vaccine trial doesn’t mean it’s not safe – it shows they’re following the right process
10 Sep, 2020 | 09:42h | UTC
A leading coronavirus vaccine trial is on hold: Scientists react
10 Sep, 2020 | 09:43h | UTCA leading coronavirus vaccine trial is on hold: scientists react – Nature